117 related articles for article (PubMed ID: 28765159)
41. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.
Nicholas MK; Lukas RV; Chmura S; Yamini B; Lesniak M; Pytel P
Semin Oncol; 2011 Apr; 38(2):243-53. PubMed ID: 21421114
[TBL] [Abstract][Full Text] [Related]
42. The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered.
Gan HK; Cvrljevic AN; Johns TG
FEBS J; 2013 Nov; 280(21):5350-70. PubMed ID: 23777544
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Denholt CL; Binderup T; Stockhausen MT; Poulsen HS; Spang-Thomsen M; Hansen PR; Gillings N; Kjær A
Nucl Med Biol; 2011 May; 38(4):509-15. PubMed ID: 21531288
[TBL] [Abstract][Full Text] [Related]
44. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.
Chamberlain MC; Sanson M
Neurology; 2015 May; 84(19):2007. PubMed ID: 25964481
[No Abstract] [Full Text] [Related]
45. Epidermal growth factor receptor gene expression in high grade gliomas.
Larysz D; Kula D; Kowal M; Rudnik A; Jarząb M; Blamek S; Bierzyńska-Macyszyn G; Kowalska M; Bażowski P; Jarząb B
Folia Neuropathol; 2011; 49(1):28-38. PubMed ID: 21455841
[TBL] [Abstract][Full Text] [Related]
46. Gauging heterogeneity in primary versus recurrent glioblastoma.
Niclou SP
Neuro Oncol; 2015 Jul; 17(7):907-9. PubMed ID: 25972456
[No Abstract] [Full Text] [Related]
47. Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.
Mischel PS; Nelson SF; Cloughesy TF
Cancer Biol Ther; 2003; 2(3):242-7. PubMed ID: 12878856
[TBL] [Abstract][Full Text] [Related]
48. Glioblastoma genetics: in rapid flux.
Purow BW; Schiff D
Discov Med; 2010 Feb; 9(45):125-31. PubMed ID: 20193638
[TBL] [Abstract][Full Text] [Related]
49. Metabolism: Fusion power.
Harjes U
Nat Rev Cancer; 2018 Jan; 18(2):66. PubMed ID: 29368747
[No Abstract] [Full Text] [Related]
50. A systems biology-based gene expression classifier of glioblastoma predicts survival with solid tumors.
Zhang J; Liu B; Jiang X; Zhao H; Fan M; Fan Z; Lee JJ; Jiang T; Jiang T; Song SW
PLoS One; 2009 Jul; 4(7):e6274. PubMed ID: 19609451
[TBL] [Abstract][Full Text] [Related]
51. The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?
Purow B
J Neurooncol; 2011 Jul; 103(3):429-36. PubMed ID: 21082214
[TBL] [Abstract][Full Text] [Related]
52. Mapping uncharted territory: a gene expression signature for precision glioblastoma therapeutics.
Skinner KR; Nabors LB; Miller CR
Neuro Oncol; 2020 Dec; 22(12):1713-1714. PubMed ID: 33257985
[No Abstract] [Full Text] [Related]
53. Genomic landscape of glioblastoma and the potential clinical utility.
Wang CJ; Choe KS
CNS Oncol; 2014 May; 3(3):169-72. PubMed ID: 25055121
[No Abstract] [Full Text] [Related]
54. Same Script, Different Cast: Different Cell Origins Shape Molecular Features and Therapeutic Response in Glioblastoma.
Wu S; Mischel PS
Cancer Cell; 2020 Sep; 38(3):311-313. PubMed ID: 32931740
[TBL] [Abstract][Full Text] [Related]
55. Head of the Class: OLIG2 and Glioblastoma Phenotype.
Leelatian N; Ihrie RA
Cancer Cell; 2016 May; 29(5):613-615. PubMed ID: 27165737
[TBL] [Abstract][Full Text] [Related]
56. Phenotype Switching in Glioblastoma Promotes Therapy Escape.
Cancer Discov; 2023 Mar; 13(3):525. PubMed ID: 36637349
[TBL] [Abstract][Full Text] [Related]
57. Glioblastoma: Molecular Mechanisms and Clinical Trials.
Liau LM
Neurosurg Clin N Am; 2021 Apr; 32(2):xiii. PubMed ID: 33781510
[No Abstract] [Full Text] [Related]
58. Glioblastoma heterogeneity and more accurate representation in research models.
Guerrero-Cázares H; Chen L; Quiñones-Hinojosa A
World Neurosurg; 2012 Dec; 78(6):594-6. PubMed ID: 22120218
[No Abstract] [Full Text] [Related]
59. Brain tumors: molecular biology and targeted therapies.
Hegi ME; Murat A; Lambiv WL; Stupp R
Ann Oncol; 2006 Sep; 17 Suppl 10():x191-7. PubMed ID: 17018723
[No Abstract] [Full Text] [Related]
60. Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma.
Qin EY; Cooper DD; Abbott KL; Lennon J; Nagaraja S; Mackay A; Jones C; Vogel H; Jackson PK; Monje M
Cell; 2017 Aug; 170(5):845-859.e19. PubMed ID: 28823557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
